The Effect of Joint Range of Motion and Benson Relaxation Exercises on Dialysis Adequacy, Treatment Adherence, and Quality of Life in Hemodialysis Patients

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

• Ages 18 years and older
• All sexes
• No healthy volunteers
• Adult, Older adult

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

About this study

Conditions

Hemodialysis Patients

Being tested

Range of Motion Intervention (ROMI), Benson Relaxation Exercise Intervention (BREI)

Keywords

Hemodialysis, range of motion, Benson relaxation exercises, quality of life, dialysis adequacy, treatment adherence

Medical subject headings

Treatment Adherence and Compliance

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

• Range of Motion Intervention (ROMI)Other

  Procedure Steps:

  • The patient is evaluated for factors that may affect the procedure (restricted movement, presence of fistula, history of surgery, etc.). • The patient is placed in the supine position. • Movements are performed from head to toe. • Each movement is repeated 3-5 times. • With the patient's head and chin supported, the following movements are performed sequentially: flexion, extension, hyperextension, right lateral flexion, left lateral flexion, right rotation, and left rotation of the head.
  • The patient's shoulder is supported. Without bending the elbow, the following movements are performed sequentially: flexion, extension, adduction, abduction, internal and external rotation. The same movements are performed sequentially for the forearm, wrist, and fingers.
  • All movements are performed sequentially for the other arm, hip, and both legs.

• Benson Relaxation Exercise Intervention (BREI)Other

  Procedure Steps:

  • The patient is asked to choose a word that is important to them and that they can focus their attention on (health, well-being, love, affection, God, etc.), a prayer, or a short sentence.
  • They are asked to close their eyes in a calm environment and in a comfortable position.
  • They are asked to slowly relax their muscles from foot to head (foot, calf, thigh, abdomen, chest, shoulder, neck, and head). • They are asked to breathe in through their nose and repeat the chosen word as they exhale.
  • They are asked to continue the procedure for 10-20 minutes. They are informed that they can open their eyes occasionally to monitor the time, but they should not set an alarm. • After the procedure is complete, they are asked to wait a few minutes with their eyes closed. Then, they are asked to wait a few minutes with their eyes open. • The patient is informed that they should not worry about whether they performed the procedure correctly.

What is being measured

The primary outcome is the main question the study is designed to answer.

1. SEVEN-POINT SUBJECTIVE GLOBAL ASSESSMENT (SGD-7P)

   It can be used to determine dialysis adequacy. The SGD-7P scale will be used to assess the nutritional status of patients. The SGD-7P was developed by Detsky et al. in 1984. The Turkish validity and reliability study was conducted by Eminsoy et al. in 2019. The scale has five evaluation criteria for medical history and three evaluation criteria for physical characteristics. For each evaluation criterion, an option is selected on a scale of 1-7 points. As a result of the average of the obtained scores, it is classified as 6-7 points (well-nourished), 3-5 points (mild-moderate malnutrition), and 1-2 points (severe malnutrition).

   Measured: From enrollment to the end of treatment at 8 weeks

2. END-STAGE RENAL FAILURE - COMPLIANCE SCALE

   The scale was developed by Kim and Evangelista (2010). The Turkish adaptation, validity, and reliability of the scale were carried out by Ok and Kutlu (2017). The SDBYUÖ consists of 4 subscales: hemodialysis participation, medication adherence, fluid adherence, and diet adherence. Hemodialysis participation is the sum of the scores of items 1, 3, and 5; medication adherence is the score of item 6; fluid adherence is the score of item 8; and diet adherence is the score of item 9. The total score of the scale ranges from 0 to 1200. A higher score indicates higher treatment adherence.

   Measured: From enrollment to the end of treatment at 8 weeks

3. Kidney Disease Patients Quality of Life Scale (KDQOL-36)

   The Turkish validity and reliability study of the scale, developed by Hayy et al. in 1994, was conducted by Yıldırım et al. in 2007. The scale consists of two scales: the SF-12 form, comprising a summary of the physical component and a summary of the mental component. It comprises a total of 4 sections and 36 items covering the burden of kidney disease, symptoms of kidney disease, and effects of kidney disease. There is no total score; each dimension is scored between 0 and 100. A score closer to 100 indicates a high quality of life, while a score closer to 0 indicates a low quality of life.

   Measured: From enrollment to the end of treatment at 8 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

1. First posted13 Feb 2026
2. Study start1 Mar 2026 (estimated)
3. Primary completion1 Apr 2026 (estimated)
4. Study completion16 May 2026 (estimated)

Resources

• Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
• Other trials for Hemodialysis PatientsStudies of the same condition, open and under way.
• What the trial phases meanHow a treatment moves from first tests in people to approval.

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.